| Literature DB >> 25763203 |
Gulsum Kavalci1, Filiz Banu Ethemoglu1, Asli Batuman1, Dilber Kumral1, Cengizhan Emre1, Meltem Surgit1, Alev Akdikan1, Cemil Kavalci2.
Abstract
BACKGROUND: Poisoning is a global public health problem. Self-poisoning has potentially serious consequences. Follow-up studies have found that 3-10% of self-harm patients eventually succeed.Entities:
Keywords: Cost; Intensive Care Unit; Poisoning
Year: 2014 PMID: 25763203 PMCID: PMC4329943 DOI: 10.5812/ircmj.10856
Source DB: PubMed Journal: Iran Red Crescent Med J ISSN: 2074-1804 Impact factor: 0.611
Inclusion/Exclusion Criteria
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Patients over 16 years of age | patients under 16 years of age |
| Patients who were admitted to the hospital’s ICU with deliberate self-poisoning |
Demographic Features of Patients[a]
| Demographic Features | Results | Cost, $ | P Value |
|---|---|---|---|
| P > 0.05 | |||
| Male | 20 (32.3) | 401.57 ± 326.32 | |
| Female | 51 (71.8) | 329.57 ± 218.47 | |
|
| P > 0.05 | ||
| 16-25 | 30 (42.3) | 356.40 ± 248.54 | |
| 26-35 | 27 (38) | 268.05 ± 163.99 | |
| 36-45 | 7 (9.9) | 509.12 ± 303.97 | |
| 46-55 | 5 (7) | 473.43 ± 490.97 | |
| 56-65 | 1 (1.4) | 498.20 | |
| > 66 | 1 (1.4) | 480.66 |
aData are Presented as No. (%) or Mean ± SD.
Poisoning Agents and Treatment Modalities[a]
| Results, N (%) | Cost, $ | P Value | |
|---|---|---|---|
| P > 0.05 | |||
| Gastric lavage | 35 (49.3) | 357.30 ± 272.13 | |
| Active charcoal | 38 (53.5) | 353.19 ± 264.33 | |
| Antidote | 9 (12.7) | 413.89 ± 125.18 | |
|
| P > 0.05 | ||
| Pharmaceutical | 68 (95.8) | 351.265 ± 256.48 | |
| Alcohol | 2 (2.8) | 232.88 ± 173.49 | |
| Pesticide | 1 (1.4) | 487.82 |
aData are Presented as No. (%) or Mean ± SD.
Pharmaceutical Agents (one or multiple) Involved in Poisoning[a]
| Results | Cost, $ | P Value | |
|---|---|---|---|
| P < 0.05 | |||
| 1 | 48 (67.6) | 320.11 ± 198.6 | |
| 2 | 10 (14.1) | 557.52 ± 468.50 | |
| 3 | 6 (8.5) | 295.65 ± 124.35 | |
| 4 | 7 (9.9) | 303.51 ± 93.13 | |
|
| P > 0.05 | ||
| Antidepressant | 31 (43.7) | 318.59 ± 247.64 | |
| Analgesic | 28 (39.4) | 365.08 ± 221.05 | |
| Other psychotropic | 3 (4.2) | 827.06 ± 668.83 | |
| Antiepileptic | 2 (2.8) | 266.90 ± 24.69 | |
| Antibiotic | 6 (8.5) | 306.48 ± 201.73 | |
| Antihypertensives | 4 (5.6) | 558.28 ± 520.65 | |
| Others | 16 (22.5) | 435.62 ± 298.17 | |
| Unidentifiable | 9 (12.7) | 270.71 ± 185.41 |
aData are Presented as No. (%) or Mean ± SD.
Cost and Length of Stay[a]
| Length of Stay | Results | Cost, $ | P Value |
|---|---|---|---|
|
| 8 (11.3) | 61.41 ± 52.36 | < 0.05 |
|
| 31 (43.7) | 236.72 ± 85.86 | |
|
| 24 (33.8) | 423.65 ± 128.87 | |
|
| 5 (7) | 648.70 ± 103.02 | |
|
| 2 (2.8) | 1150.98 ± 4.88 | |
|
| 1 (1.4) | 1300 |
aData are Presented as No. (%) or Mean ± SD.
Factors Effective on Patient Cost
| Variable | RR (95% CI) | P Value |
|---|---|---|
|
| 0.96 (209.1-262.3) | 0.000 |
|
| 0.189 (11.4-183.3) | 0.027 |
|
| -0.215 (-365.6-103.1) | 0.001 |
|
| -0.061 (-95.5-26.8) | 0.265 |
|
| 0.090 (-4.5-46.9) | 0.104 |
|
| 0.012 (-40.3-46.5) | 0.886 |
|
| -0.102 (-122.8-19.6) | 0.152 |
|
| 0.020 (-149.7-211.1) | 0.734 |
|
| 0.020 (-139.0-199.4) | 0.722 |
|
| -0.047 (-180.6-95.9) | 0.541 |
|
| 0.002 (-170.1-175.8) | 0.974 |
|
| -0.005 (-231.0-211.4) | 0.930 |
|
| 0.080 (-41.6-121.9) | 0.329 |
|
| -0.144 (-157.6-12.1) | 0.091 |
|
| -0.092 (-202.2-63.3) | 0.299 |
aLogistic regression analysis.